Ernexa Therapeutics Inc. of CAMBRIDGE, MA filed a DEF 14A with the SEC on 2025-04-14. Industry: Pharmaceutical Preparations.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | formdef14a.htm |
| 2 | GRAPHIC | def14a_001.jpg |
| 3 | GRAPHIC | def14a_002.jpg |
| 4 | GRAPHIC | def14a_004.jpg |
| 5 | GRAPHIC | proxy_001.jpg |
| 6 | GRAPHIC | proxy_002.jpg |
| 7 | EX-101.SCH | XBRL SCHEMA FILE |
| 8 | EX-101.DEF | XBRL DEFINITION FILE |
| 9 | EX-101.LAB | XBRL LABEL FILE |
| 10 | EX-101.PRE | XBRL PRESENTATION FILE |
| 23 | XML | EXTRACTED XBRL INSTANCE DOCUMENT |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-05-11 | DEFA14A |
| 2026-05-11 | DEF 14A |
| 2026-04-13 | DEF 14C |
| 2026-04-01 | PRE 14C |
| 2025-04-14 | DEF 14A |
| 2025-04-03 | PRE 14A |
| 2024-10-07 | DEF 14A |
| 2024-09-27 | PRE 14A |
| 2023-05-10 | DEFA14A |
| 2023-05-05 | DEFA14A |
| 2023-05-05 | DEF 14A |
| 2023-04-20 | PRE 14A |